RenovoRx raises $10M via common stock and milestone warrants in oversubscribed offering

RenovoRx, Inc.

Raised ~$10M gross from sale of 8.4M shares, 2.2M pre-funded warrants, and 5.3M milestone warrants to 15 investors (including insiders).
Milestone warrants (50% coverage) expire upon $1.5M quarterly product revenue or Mar 30, 2029; exercise price $1.751 (institutional), $1.933 (insiders).
Proceeds to boost RenovoCath commercial rollout and fund Phase III TIGeR-PaC trial to full enrollment by mid-2026.
Insider participation at $1.0288/share vs $0.938 for institutions to comply with Nasdaq pricing rules.
Company must file resale registration within 30 days; liquidated damages of up to 10% of subscription amount if delayed.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

RenovoRx, Inc. entered into Securities Purchase Agreement with 15 accredited investors or qualified institutional buyers valued at aggregate gross proceeds of approximately $10 million (effective 2026-03-17).

Action: entry
Agreement: equity purchase
Counterparty: 15 accredited investors or qualified institutional buyers
Value: aggregate gross proceeds of approximately $10 million
Effective: 2026-03-17

Exact text from the filing

On March 17, 2026, RenovoRx, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) in connection with a private placement offering by the Company (the “Offering”) to 15 accredited investors or qualified institutional buyers (the “Investors”), five of whom are directors, officers or employees of the Company (the “Insiders”) and the remaining are non-affiliated institutional investors (the “Institutional Investors”).

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

RenovoRx, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-012058

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.